Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (24937) 24937
Journal Article (3927) 3927
Publication (198) 198
Book Review (62) 62
Newspaper Article (38) 38
Newsletter (33) 33
Book Chapter (29) 29
Book / eBook (25) 25
Dissertation (9) 9
Magazine Article (9) 9
Conference Proceeding (4) 4
Government Document (3) 3
Web Resource (3) 3
Data Set (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (25025) 25025
organic chemistry (24995) 24995
metallurgy (24940) 24940
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (24937) 24937
human necessities (24479) 24479
hygiene (24462) 24462
medical or veterinary science (24461) 24461
preparations for medical, dental, or toilet purposes (23935) 23935
specific therapeutic activity of chemical compounds ormedicinal preparations (23200) 23200
heterocyclic compounds (14979) 14979
acyclic or carbocyclic compounds (6860) 6860
general tagging of cross-sectional technologies spanning over several sections of the ipc (3340) 3340
general tagging of new technological developments (3340) 3340
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (3340) 3340
derivatives thereof (2556) 2556
nucleic acids (2500) 2500
sugars (2498) 2498
nucleotides (2497) 2497
nucleosides (2493) 2493
technologies or applications for mitigation or adaptation againstclimate change (2235) 2235
selenium (2171) 2171
humans (2123) 2123
specific use of cosmetics or similar toiletpreparations (1947) 1947
biochemistry (1890) 1890
microbiology (1819) 1819
enzymology (1800) 1800
wine (1795) 1795
beer (1793) 1793
mutation or genetic engineering (1793) 1793
spirits (1793) 1793
vinegar (1793) 1793
peptides (1769) 1769
animals (1674) 1674
male (1558) 1558
selenium - therapeutic use (1481) 1481
index medicus (1434) 1434
agriculture (1239) 1239
fishing (1234) 1234
animal husbandry (1233) 1233
forestry (1233) 1233
trapping (1233) 1233
hunting (1232) 1232
climate change mitigation technologies in the production orprocessing of goods (1227) 1227
culture media (1220) 1220
compositions thereof (1214) 1214
microorganisms or enzymes (1214) 1214
propagating, preserving or maintaining microorganisms (1214) 1214
biocides, e.g. as disinfectants, as pesticides, as herbicides (1213) 1213
pest repellants or attractants (1213) 1213
plant growth regulators (1213) 1213
preservation of bodies of humans or animals or plants or partsthereof (1213) 1213
female (1184) 1184
apparatus therefor (1145) 1145
technical subjects covered by former uspc (1141) 1141
general methods of organic chemistry (1140) 1140
technologies for adaptation to climate change (1112) 1112
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (1045) 1045
performing operations (980) 980
transporting (980) 980
physics (791) 791
testing (771) 771
measuring (768) 768
oxidative stress (748) 748
investigating or analysing materials by determining theirchemical or physical properties (736) 736
rats (676) 676
compositions based thereon (670) 670
organic macromolecular compounds (670) 670
their preparation or chemical working-up (670) 670
foods or foodstuffs (651) 651
their treatment, not covered by other classes (651) 651
compositions or test papers therefor (569) 569
condition-responsive control in microbiological orenzymological processes (569) 569
measuring or testing processes involving enzymes, nucleicacids or microorganisms (569) 569
processes of preparing such compositions (569) 569
adult (553) 553
antioxidants (553) 553
antioxidants - therapeutic use (552) 552
nanotechnology (529) 529
middle aged (518) 518
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (490) 490
mice (490) 490
vitamin e - therapeutic use (485) 485
manufacture or treatment of nanostructures (479) 479
measurement or analysis of nanostructures (479) 479
specific uses or applications of nanostructures (479) 479
dietary supplements (463) 463
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (455) 455
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (449) 449
preservation of foods or foodstuffs, in general (449) 449
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (449) 449
dyes (441) 441
adhesives (438) 438
miscellaneous applications of materials (438) 438
miscellaneous compositions (438) 438
natural resins (438) 438
paints (438) 438
polishes (438) 438
cancer (423) 423
oncology (409) 409
biochemistry & molecular biology (395) 395
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25203) 25203
French (7720) 7720
German (3953) 3953
Chinese (1570) 1570
Spanish (1013) 1013
Japanese (630) 630
Russian (489) 489
Korean (431) 431
Portuguese (406) 406
Norwegian (392) 392
Danish (261) 261
Czech (260) 260
Hungarian (175) 175
Polish (171) 171
Finnish (155) 155
Swedish (99) 99
Hebrew (93) 93
Slovak (91) 91
Slovenian (83) 83
Bulgarian (70) 70
Icelandic (64) 64
Dutch (57) 57
Croatian (56) 56
Italian (50) 50
Serbian (49) 49
Turkish (43) 43
Romanian (41) 41
Estonian (38) 38
Ukrainian (35) 35
Lithuanian (27) 27
Greek (26) 26
Arabic (10) 10
Latvian (6) 6
Indonesian (5) 5
Moldavian (3) 3
Bosnian (2) 2
Afrikaans (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Drugs for preventing lung cancer in healthy people
by Cortés-Jofré, Marcela and Rueda, José-Ramón and Corsini-Muñoz, Gilda and Fonseca-Cortés, Carolina and Caraballoso, Magali and Bonfill Cosp, Xavier
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 10, Issue 10, p. CD002141
Background This is an updated version of the original review published in Issue 2, 2003. Some studies have suggested a protective effect of antioxidant... 
Vitamins [therapeutic use] | Minerals [therapeutic use] | VITAMIN-E | alpha-Tocopherol [therapeutic use] | Humans | RANDOMIZED-TRIAL | Lung Neoplasms [prevention & control] | Randomized Controlled Trials as Topic | Vitamin A [therapeutic use] | BASE-LINE CHARACTERISTICS | LONG-TERM SUPPLEMENTATION | MEDICINE, GENERAL & INTERNAL | BETA-CAROTENE SUPPLEMENTATION | 2ND PRIMARY TUMORS | SQUAMOUS-CELL CARCINOMA | CARDIOVASCULAR-DISEASE | RETINOL EFFICACY TRIAL | beta Carotene [therapeutic use] | PLACEBO-CONTROLLED TRIAL | Health Status | Dietary Supplements | beta Carotene - therapeutic use | Lung Neoplasms - mortality | Male | Vitamins - therapeutic use | alpha-Tocopherol - therapeutic use | Vitamin A - therapeutic use | Minerals - therapeutic use | Ascorbic Acid - therapeutic use | Lung Neoplasms - prevention & control | Female | Selenium Compounds - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
by Lippman, Scott M and Klein, Eric A and Goodman, Phyllis J and Lucia, M. Scott and Thompson, Ian M and Ford, Leslie G and Parnes, Howard L and Minasian, Lori M and Gaziano, J. Michael and Hartline, Jo Ann and Parsons, J. Kellogg and Bearden, James D and Crawford, E. David and Goodman, Gary E and Claudio, Jaime and Winquist, Eric and Cook, Elise D and Karp, Daniel D and Walther, Philip and Lieber, Michael M and Kristal, Alan R and Darke, Amy K and Arnold, Kathryn B and Ganz, Patricia A and Santella, Regina M and Albanes, Demetrius and Taylor, Philip R and Probstfield, Jeffrey L and Jagpal, T. J and Crowley, John J and Meyskens, Frank L and Baker, Laurence H and Coltman, Charles A
JAMA, ISSN 0098-7484, 01/2009, Volume 301, Issue 1, pp. 39 - 51
CONTEXT Secondary analyses of 2 randomized controlled trials and supportive epidemiologic and preclinical data indicated the potential of selenium and vitamin... 
BREAST-CANCER | SUPPLEMENTATION | MORTALITY | MEDICINE, GENERAL & INTERNAL | BETA-CAROTENE | NUTRITIONAL PREVENTION | CARDIOVASCULAR-DISEASE | ALPHA-TOCOPHEROL | RANDOMIZED CONTROLLED-TRIAL | CELL-LINES | CARCINOMA | Double-Blind Method | Humans | Middle Aged | Male | Neoplasms - prevention & control | Treatment Outcome | Prostatic Neoplasms - epidemiology | Selenomethionine - therapeutic use | Selenium - therapeutic use | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Vitamin E - therapeutic use | Aged | Prostatic Neoplasms - prevention & control | Dietary Supplements | Neoplasms - epidemiology | Disease prevention | Clinical trials | Selenium | Vitamin E | Prostate cancer | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease
by Weekley, Claire M and Harris, Hugh H
Chemical Society Reviews, ISSN 0306-0012, 11/2013, Volume 42, Issue 23, pp. 887 - 8894
The biological activity of selenium is dependent upon its speciation. We aim to integrate selenium speciation and metabolism into a discussion of the... 
SODIUM SELENITE | PROTEIN-KINASE-C | BETA-ELIMINATION REACTIONS | INDUCED OXIDATIVE STRESS | PROSTATE-CANCER | GLUTATHIONE-PEROXIDASE ACTIVITY | LUNG-CANCER CELLS | CONTAINING AMINO-ACIDS | CHEMISTRY, MULTIDISCIPLINARY | THIOREDOXIN REDUCTASE-ACTIVITY | HPLC-ICP-MS | Selenocysteine - metabolism | Selenomethionine - metabolism | Reactive Oxygen Species - metabolism | Humans | Neoplasms - prevention & control | Selenium Compounds - metabolism | Clinical Trials as Topic | Histone Deacetylase Inhibitors - chemistry | Selenoproteins - metabolism | Selenomethionine - therapeutic use | Selenoproteins - chemistry | Cystine - metabolism | Cystine - therapeutic use | Sulfhydryl Compounds - chemistry | Selenocysteine - therapeutic use | Histone Deacetylase Inhibitors - metabolism | Selenocysteine - analogs & derivatives | Cystine - analogs & derivatives | Dietary Supplements | Selenium Compounds - therapeutic use | Organoselenium Compounds - metabolism | Organoselenium Compounds - therapeutic use | Selenium compounds | Pathways | Medical services | Selenium | Biological | Metabolism | Chemical compounds | Speciation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Dietary supplements for established atopic eczema
by Bath-Hextall, Fiona J and Bath-Hextall, Fiona J and Jenkinson, Claire and Jenkinson, Claire and Humphreys, Rosemary and Humphreys, Rosemary and Williams, Hywel C and Williams, Hywel C
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 2012, Issue 2, p. CD005205
Background Many people with atopic eczema are reluctant to use the most commonly recommended treatments because they fear the long-term health effects. As a... 
UNITED-STATES | VITAMIN-D | CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | PULP OILS | DERMATITIS | DOUBLE-BLIND | REVISED NOMENCLATURE | FATTY-ACIDS | HEALTH-CARE | HIPPOPHAE-RHAMNOIDES SEED | Selenium - therapeutic use | Humans | Dermatitis, Atopic - diet therapy | Pyridoxine - therapeutic use | Vitamin E - therapeutic use | Vitamin D - therapeutic use | Vitamins - therapeutic use | Dietary Supplements | Plant Oils - therapeutic use | Zinc - therapeutic use | Fish Oils - therapeutic use | Randomized Controlled Trials as Topic
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patients
by Janka, Vašková and Ladislav, Kočan and Jozef, Firment and Ladislav, Vaško
Wiener klinische Wochenschrift, ISSN 0043-5325, 6/2013, Volume 125, Issue 11, pp. 316 - 325
A prospective observational study of parenteral selenium supplementation started in January 2008 which included 72 septic patients with APACHE II scores... 
Oxidative stress | Selen | Oxidativer Stress | Künstliche Ernährung | Internal Medicine | Medicine/Public Health, general | Artificial nutrition | Pneumology/Respiratory System | Medicine & Public Health | Gastroenterology | Sepsis | Selenium | Endocrinology | Prevalence | Prospective Studies | Oxidoreductases - metabolism | Risk Assessment | Antioxidants - metabolism | Humans | Middle Aged | Male | Survival Rate | Treatment Outcome | Enzyme Activation - drug effects | Sepsis - mortality | Selenium - therapeutic use | Sepsis - drug therapy | Antioxidants - therapeutic use | Sepsis - metabolism | Aged, 80 and over | Adult | Female | Aged | Dietary Supplements | Slovakia - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
by Brown, B. Greg and Zhao, Xue-Qiao and Chait, Alan and Fisher, Lloyd D and Cheung, Marian C and Morse, Josh S and Dowdy, Alice A and Marino, Emily K and Bolson, Edward L and Alaupovic, Petar and Frohlich, Jiri and Serafini, Leny and Huss-Frechette, Ellen and Wang, Shari and DeAngelis, Debbie and Dodek, Arthur and Albers, John J
The New England Journal of Medicine, ISSN 0028-4793, 11/2001, Volume 345, Issue 22, pp. 1583 - 1592
Patients with coronary disease and low high-density lipoprotein (HDL) cholesterol levels are at risk for coronary events. This study found that a combination... 
REGRESSION | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | HEPATIC LIPASE | PLASMA | CHOLESTEROL | LOW-DENSITY-LIPOPROTEIN | CARDIOVASCULAR-DISEASE | ATHEROSCLEROSIS | ARTERY DISEASE | PROGRESSION | Simvastatin - therapeutic use | beta Carotene - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Coronary Disease - mortality | Drug Interactions | Niacin - therapeutic use | Ascorbic Acid - therapeutic use | Lipids - blood | Cardiovascular Diseases - mortality | Niacin - adverse effects | Cholesterol, LDL - blood | Female | Ascorbic Acid - blood | Drug Therapy, Combination | beta Carotene - blood | Hypolipidemic Agents - adverse effects | Double-Blind Method | Vitamin E - blood | Coronary Stenosis - drug therapy | Apolipoproteins - blood | Selenium - therapeutic use | alpha-Tocopherol - therapeutic use | Coronary Angiography | Antioxidants - therapeutic use | Coronary Disease - prevention & control | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cholesterol, HDL - blood | Coronary Disease - drug therapy | Hypolipidemic Agents - therapeutic use | Evaluation | Care and treatment | Simvastatin | Atherosclerosis | Coronary heart disease | Niacin | Health aspects | Cardiovascular disease | Heart attacks | Cholesterol | Colleges & universities
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Chemoprevention of colorectal cancer: Systematic review and economic evaluation
by Cooper, K and Squires, H and Carroll, C and Papaioannou, D and Booth, A and Logan, Rf and Maguire, C and Hind, D and Tappenden, P
Health Technology Assessment, ISSN 1366-5278, 2010, Volume 14, Issue 32, pp. 1 - 205
Colorectal cancer (CRC) is the third most common cancer in the UK: incidence increases with age, median age at diagnosis being over 70 years. Approximately 25%... 
Colorectal Neoplasms - epidemiology | beta Carotene - therapeutic use | Folic Acid - therapeutic use | Prognosis | Risk Assessment | Adenomatous Polyposis Coli - prevention & control | Humans | Adenomatous Polyposis Coli - epidemiology | Colorectal Neoplasms - prevention & control | Models, Economic | Colorectal Neoplasms - economics | Colorectal Neoplasms, Hereditary Nonpolyposis - prevention & control | Incidence | Selenium - therapeutic use | Antioxidants - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Calcium - therapeutic use | Colorectal Neoplasms, Hereditary Nonpolyposis - economics | Colorectal Neoplasms, Hereditary Nonpolyposis - epidemiology | Cyclooxygenase 2 Inhibitors - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Adenomatous Polyposis Coli - economics | United Kingdom - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Advances in Prostate Cancer Chemoprevention: A Translational Perspective
by Nambiar, Dhanya and Singh, Rana P
Nutrition and Cancer, ISSN 0163-5581, 01/2013, Volume 65, Issue 1, pp. 12 - 25
Chemopreventive interventions are steadily emerging as an important aspect of cancer management and control. Herein, we have discussed the major... 
VITAMIN-E | NUTRITION & DIETETICS | TRANSGENIC ADENOCARCINOMA | ONCOLOGY | GREEN TEA POLYPHENOLS | DOUBLE-BLIND | FACTOR-KAPPA-B | EPIGALLOCATECHIN GALLATE | ENCAPSULATED CURCUMIN | I CLINICAL-TRIAL | TUMOR-GROWTH | PHASE-I | Phytochemicals - therapeutic use | Humans | Male | Flavonoids - therapeutic use | Prostate - pathology | Carotenoids - therapeutic use | Vitamin E - therapeutic use | Prostate - drug effects | Genistein - therapeutic use | Prostatic Neoplasms - prevention & control | Prostatic Neoplasms - drug therapy | Anticarcinogenic Agents - therapeutic use | Disease Models, Animal | Silymarin - therapeutic use | Curcumin - therapeutic use | Chemoprevention | Risk Factors | Azasteroids - therapeutic use | Clinical Trials as Topic | Selenium - therapeutic use | Antioxidants - therapeutic use | Animals | Androgen Antagonists - therapeutic use | Dutasteride | Finasteride - therapeutic use | Polyphenols - therapeutic use | Tea - chemistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Therapeutic potential of selenium and tellurium compounds: Opportunities yet unrealised
by Tiekink, Edward R. T
Dalton Transactions, ISSN 1477-9226, 5/2012, Volume 41, Issue 21, pp. 639 - 6395
Despite being disparaged for their malodorous and toxic demeanour, compounds of selenium, a bio-essential element, and tellurium, offer possibilities as... 
ANTIOXIDANT ACTIVITY | ORGANOTELLURIUM COMPOUNDS | MECHANISM | DIPHENYL DISELENIDE | GLUTATHIONE-PEROXIDASE | ANTITHYROID DRUGS | ORGANOSELENIUM COMPOUNDS | METHIMAZOLE | EBSELEN | DERIVATIVES | CHEMISTRY, INORGANIC & NUCLEAR | Selenium - chemistry | Humans | Organometallic Compounds - therapeutic use | Drug Discovery - methods | Organometallic Compounds - chemistry | Selenium Compounds - chemistry | Tellurium - chemistry | Selenium Compounds - therapeutic use | Index Medicus | Toxicology | Summaries | Pharmacology | Selenium | Biological | Antiinfectives and antibacterials | Chemical compounds | Tellurium
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Restoration of antioxidant enzymes in the therapeutic use of selenium in septic patientsaEuro (c)
by Janka, V and Ladislav, K and Jozef, F and Ladislav, V
WIENER KLINISCHE WOCHENSCHRIFT, ISSN 0043-5325, 06/2013, Volume 125, Issue 11-12, pp. 316 - 325
A prospective observational study of parenteral selenium supplementation started in January 2008 which included 72 septic patients with APACHE II scores... 
SUPPLEMENTATION | Oxidative stress | SODIUM SELENITE | SHOCK | MEDICINE, GENERAL & INTERNAL | Artificial nutrition | COTRANSPORT | GLUTATHIONE | PATHWAY | Sepsis | Selenium | CRITICALLY-ILL PATIENTS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text A Randomized Trial of Glutamine and Antioxidants in Critically Ill Patients
by Heyland, Daren and Muscedere, John and Wischmeyer, Paul E and Cook, Deborah and Jones, Gwynne and Albert, Martin and Elke, Gunnar and Berger, Mette M and Day, Andrew G and Canadian Critical Care Trials Grp and Canadian Critical Care Trials Group
The New England Journal of Medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 16, pp. 1489 - 1497
This trial involving critically ill adults with multiorgan failure who were receiving mechanical ventilation showed that early provision of glutamine and... 
SUPPLEMENTATION | INFLAMMATORY RESPONSE SYNDROME | MEDICINE, GENERAL & INTERNAL | OXIDATIVE STRESS | SEPTIC SHOCK | NUTRITION | DYSFUNCTION | HEALTH | SELENIUM | Single-Blind Method | Multiple Organ Failure - mortality | Hospital Mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Critical Illness | Logistic Models | Male | Survival Rate | Multiple Organ Failure - therapy | Respiration, Artificial | Young Adult | Antioxidants - therapeutic use | Adolescent | Intention to Treat Analysis | Aged, 80 and over | Glutamine - therapeutic use | Adult | Antioxidants - adverse effects | Female | Aged | Multiple Organ Failure - drug therapy | Glutamine - adverse effects | Antioxidants | Health aspects | Glutamine | Intensive care units | Oxidative stress | Medical research | Intensive care | Nutrition | Mortality | Ventilation | Selenium | Supplementation | Vitamins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights